Erratum: Expression of concern: Stress-induced sphingolipid signaling: Role of type-2 neutral sphingomyelinase in murine cell apoptosis and proliferation (PLoS ONE (2010) 5: 3 (e9826) DOI: 10.1371/journal.pone.0009826);Stress-induced sphingolipid signaling: Role of type-2 neutral sphingomyelinase in murine cell apoptosis and proliferation

PLoS ONE

Volumn 5, Issue 3, 2013, Pages

  Devillard, Raphael ^a,c   Galvani, Sylvain ^a,b   Thiers, Jean Claude ^a,b   Guenet, Jean Louis ^d   Hannun, Yusuf ^e   Bielawski, Jacek ^e   Nègre Salvayre, Anne ^a,b   Salvayre, Robert ^a,b   Augé, Nathalie ^a,b  

^a CHU RANGUEIL   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d INSTITUT PASTEUR   (France)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN; SMPD3 PROTEIN, MOUSE; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; FIBROBLAST; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; HYDROLYSIS; LIVER; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; FIBROBLASTS; GENETIC VECTORS; HUMANS; HYDROLYSIS; LIPOPROTEINS, LDL; LIVER; MICE; MICE, TRANSGENIC; SPHINGOLIPIDS; SPHINGOMYELIN PHOSPHODIESTERASE; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952116099     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0208866     Document Type: Erratum

References (44)

1. Hannun YA (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274: 1855-1859.
2. Hannun YA, Obeid LM (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9: 139-150.
3. Kolesnick RN, Kronke M (1998) Regulation of ceramide production and apoptosis. Annu Rev Physiol 60: 643-665.
4. Spiegel S, Milstien S (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 4: 397-407.
5. Clarke CJ, Hannun YA (2006) Neutral sphingomyelinases and nSMase2: bridging the gaps. Biochim Biophys Acta 1758: 1893-1901.
6. Auge N, Negre-Salvayre A, Salvayre R, Levade T (2000) Sphingomyelin metabolites in vascular cell signaling and atherogenesis. Prog Lipid Res 39: 207-229.
7. Coatrieux C, Sanson M, Negre-Salvayre A, Parini A, Hannun Y, et al. (2007) MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway. Free Radic Biol Med 43: 80-89.
8. Tellier E, Negre-Salvayre A, Bocquet B, Itohara S, Hannun YA, et al. (2007) Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway. Mol Cell Biol 27: 2997-3007.
9. Marchesini N, Osta W, Bielawski J, Luberto C, Obeid LM, et al. (2004) Role for mammalian neutral sphingomyelinase 2 in confluence-induced growth arrest of MCF7 cells. J Biol Chem 279: 25101-25111.
10. Kolesnick R, Hannun YA (1999) Ceramide and apoptosis. Trends Biochem Sci 24: 224-225; author reply 227.
11. Tomiuk S, Hofmann K, Nix M, Zumbansen M, Stoffel W (1998) Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc Natl Acad Sci U S A 95: 3638-3643.
12. Zumbansen M, Stoffel W (2002) Neutral sphingomyelinase 1 deficiency in the mouse causes no lipid storage disease. Mol Cell Biol 22: 3633-3638.
13. Yabu T, Imamura S, Yamashita M, Okazaki T (2008) Identification of Mg2+-dependent neutral sphingomyelinase 1 as a mediator of heat stress-induced ceramide generation and apoptosis. J Biol Chem 283: 29971-29982.
14. Krut O, Wiegmann K, Kashkar H, Yazdanpanah B, Kronke M (2006) Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a Ctail-anchored protein. J Biol Chem 281: 13784-13793.
15. Tomiuk S, Zumbansen M, Stoffel W (2000) Characterization and subcellular localization of murine and human magnesium-dependent neutral sphingomyelinase. J Biol Chem 275: 5710-5717.
16. De Palma C, Meacci E, Perrotta C, Bruni P, Clementi E (2006) Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium. Arterioscler Thromb Vasc Biol 26: 99-105.
17. Tani M, Hannun YA (2007) Neutral sphingomyelinase 2 is palmitoylated on multiple cysteine residues. Role of palmitoylation in subcellular localization. J Biol Chem 282: 10047-10056.
18. Zeng C, Lee JT, Chen H, Chen S, Hsu CY, et al. (2005) Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ ceramide pathway in oligodendrocytes. J Neurochem 94: 703-712.
19. Aubin I, Adams CP, Opsahl S, Septier D, Bishop CE, et al. (2005) A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse. Nat Genet 37: 803-805.
20. Stoffel W, Jenke B, Block B, Zumbansen M, Koebke J (2005) Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. Proc Natl Acad Sci U S A 102: 4554-4559.
21. Wajant H (2003) Death receptors. Essays Biochem 39: 53-71.
22. Ding WX, Yin XM (2004) Dissection of the multiple mechanisms of TNF-alphainduced apoptosis in liver injury. J Cell Mol Med 8: 445-454.
23. Chen G, Goeddel DV (2002) TNF-R1 signaling: a beautiful pathway. Science 296: 1634-1635.
24. Auge N, Pieraggi MT, Thiers JC, Negre-Salvayre A, Salvayre R (1995) Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells. Biochem J 309 (Pt 3): 1015-1020.
25. Kittrell FS, Oborn CJ, Medina D (1992) Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro. Cancer Res 52: 1924-1932.
26. Auge N, Maupas-Schwalm F, Elbaz M, Thiers JC, Waysbort A, et al. (2004) Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 110: 571-578.
27. Bielawski J, Szulc ZM, Hannun YA, Bielawska A (2006) Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 39: 82-91.
28. Vieira O, Escargueil-Blanc I, Jurgens G, Borner C, Almeida L, et al. (2000) Oxidized LDLs alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis. FASEB J 14: 532-542.
29. Auge N, Garcia V, Maupas-Schwalm F, Levade T, Salvayre R, et al. (2002) Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways. Arterioscler Thromb Vasc Biol 22: 1990-1995.
30. Brouckaert P, Libert C, Everaerdt B, Takahashi N, Cauwels A, et al. (1993) Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6. Immunobiology 187: 317-329.
31. Hofmann K, Tomiuk S, Wolff G, Stoffel W (2000) Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. Proc Natl Acad Sci U S A 97: 5895-5900.
32. Wilson NS, Dixit V, Ashkenazi A (2009) Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat Immunol 10: 348-355.
33. Hofmann K, Dixit VM (1998) Ceramide in apoptosis-does it really matter? Trends Biochem Sci 23: 374-377.
34. Carpinteiro A, Dumitru C, Schenck M, Gulbins E (2008) Ceramide-induced cell death in malignant cells. Cancer Lett 264: 1-10.
35. Smith EL, Schuchman EH (2008) The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J 22: 3419-3431.
36. Clarke CJ, Truong TG, Hannun YA (2007) Role for neutral sphingomyelinase-2 in tumor necrosis factor alpha-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2. J Biol Chem 282: 1384-1396.
37. Kim WJ, Okimoto RA, Purton LE, Goodwin M, Haserlat SM, et al. (2008) Mutations in the neutral sphingomyelinase gene SMPD3 implicate the ceramide pathway in human leukemias. Blood 111: 4716-4722.
38. Escargueil-Blanc I, Andrieu-Abadie N, Caspar-Bauguil S, Brossmer R, Levade T, et al. (1998) Apoptosis and activation of the sphingomyelin-ceramide pathway induced by oxidized low density lipoproteins are not causally related in ECV-304 endothelial cells. J Biol Chem 273: 27389-27395.
39. Escargueil-Blanc I, Salvayre R, Negre-Salvayre A (1994) Necrosis and apoptosis induced by oxidized low density lipoproteins occur through two calciumdependent pathways in lymphoblastoid cells. FASEB J 8: 1075-1080.
40. Porn-Ares MI, Saido TC, Andersson T, Ares MP (2003) Oxidized low-density lipoprotein induces calpain-dependent cell death and ubiquitination of caspase 3 in HMEC-1 endothelial cells. Biochem J 374: 403-411.
41. Vindis C, Elbaz M, Escargueil-Blanc I, Auge N, Heniquez A, et al. (2005) Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDL-induced apoptosis. Arterioscler Thromb Vasc Biol 25: 639-645.
42. Grassme H, Riethmuller J, Gulbins E (2007) Biological aspects of ceramideenriched membrane domains. Prog Lipid Res 46: 161-170.
43. Garcia-Ruiz C, Colell A, Mari M, Morales A, Calvo M, et al. (2003) Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice. J Clin Invest 111: 197-208.
44. Osawa M, Dace A, Tong KI, Valiveti A, Ikura M, et al. (2005) Mg2+ and Ca2+ differentially regulate DNA binding and dimerization of DREAM. J Biol Chem 280: 18008-18014.